209 related articles for article (PubMed ID: 31382500)
1. Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis.
Jalil A; Bourgeois T; Ménégaut L; Lagrost L; Thomas C; Masson D
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382500
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor agonist upregulates LPCAT3 in human aortic endothelial cells.
Bousquet D; Nader E; Connes P; Guillot N
Front Physiol; 2024; 15():1388404. PubMed ID: 38694208
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis.
Varin A; Thomas C; Ishibashi M; Ménégaut L; Gautier T; Trousson A; Bergas V; de Barros JP; Narce M; Lobaccaro JM; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1357-65. PubMed ID: 25838428
[TBL] [Abstract][Full Text] [Related]
4. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
Wang J; Li J; Fu Y; Zhu Y; Lin L; Li Y
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38362962
[TBL] [Abstract][Full Text] [Related]
5. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition.
Rong X; Albert CJ; Hong C; Duerr MA; Chamberlain BT; Tarling EJ; Ito A; Gao J; Wang B; Edwards PA; Jung ME; Ford DA; Tontonoz P
Cell Metab; 2013 Nov; 18(5):685-97. PubMed ID: 24206663
[TBL] [Abstract][Full Text] [Related]
6. Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.
Ishibashi M; Varin A; Filomenko R; Lopez T; Athias A; Gambert P; Blache D; Thomas C; Gautier T; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1171-9. PubMed ID: 23580142
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptors in lipid signalling and membrane homeostasis.
Wang B; Tontonoz P
Nat Rev Endocrinol; 2018 Aug; 14(8):452-463. PubMed ID: 29904174
[TBL] [Abstract][Full Text] [Related]
8. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
[TBL] [Abstract][Full Text] [Related]
9. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
10. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
12. Alteration of plasma phospholipid fatty acid profile in patients with septic shock.
Rival T; Cinq-Frais C; Silva-Sifontes S; Garcia J; Riu B; Salvayre R; Genestal M; Caspar-Bauguil S
Biochimie; 2013 Nov; 95(11):2177-81. PubMed ID: 23954620
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional effects of phospholipid fatty acid profile on rainbow trout liver cells exposed to methylmercury.
Ferain A; Bonnineau C; Neefs I; Das K; Larondelle Y; Rees JF; Debier C; Lemaire B
Aquat Toxicol; 2018 Jun; 199():174-187. PubMed ID: 29649756
[TBL] [Abstract][Full Text] [Related]
14. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver.
Gnoni A; Giudetti AM
J Physiol Biochem; 2016 Sep; 72(3):485-94. PubMed ID: 27312217
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid Remodeling in Physiology and Disease.
Wang B; Tontonoz P
Annu Rev Physiol; 2019 Feb; 81():165-188. PubMed ID: 30379616
[TBL] [Abstract][Full Text] [Related]
16. Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis.
Raphael W; Sordillo LM
Int J Mol Sci; 2013 Oct; 14(10):21167-88. PubMed ID: 24152446
[TBL] [Abstract][Full Text] [Related]
17. Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner.
Han X; Cui ZY; Song J; Piao HQ; Lian LH; Hou LS; Wang G; Zheng S; Dong XX; Nan JX; Wu YL
Chem Biol Interact; 2019 Sep; 311():108794. PubMed ID: 31421115
[TBL] [Abstract][Full Text] [Related]
18. Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease.
Kim H; Park C; Kim TH
Cells; 2023 May; 12(9):. PubMed ID: 37174692
[TBL] [Abstract][Full Text] [Related]
19. ER phospholipid composition modulates lipogenesis during feeding and in obesity.
Rong X; Wang B; Palladino EN; de Aguiar Vallim TQ; Ford DA; Tontonoz P
J Clin Invest; 2017 Oct; 127(10):3640-3651. PubMed ID: 28846071
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated fatty acid-phospholipid remodeling and inflammation.
Robichaud PP; Surette ME
Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):112-8. PubMed ID: 25692925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
